loadpatents
Patent applications and USPTO patent grants for RIVIER; Jean E. F..The latest application filed is for "urocortin 2 analogs and uses thereof".
Patent | Date |
---|---|
Urocortin 2 Analogs And Uses Thereof App 20180271945 - VALE, JR.; Wylie W. ;   et al. | 2018-09-27 |
Urocortin 2 analogs and uses thereof Grant 9,572,866 - Vale, Jr. , et al. February 21, 2 | 2017-02-21 |
Urocortin-iii And Uses Thereof App 20160375102 - VALE, JR.; Wylie W. ;   et al. | 2016-12-29 |
Urocortin-III and uses thereof Grant 9,388,229 - Vale, Jr. , et al. July 12, 2 | 2016-07-12 |
Urocortin 2 Analogs And Uses Thereof App 20160022780 - VALE, JR.; Wylie W. ;   et al. | 2016-01-28 |
Urocortin 2 Analogs And Uses Thereof App 20150315257 - VALE, JR.; Wylie W. ;   et al. | 2015-11-05 |
Cyclic CRF antagonist peptides Grant 9,035,022 - Rivier May 19, 2 | 2015-05-19 |
Urocortin-iii And Uses Thereof App 20140288161 - VALE, JR.; Wylie W. ;   et al. | 2014-09-25 |
Somatostatin receptor 2 antagonists Grant 8,691,761 - Rivier , et al. April 8, 2 | 2014-04-08 |
Urocortin-III and uses thereof Grant 8,669,092 - Vale, Jr. , et al. March 11, 2 | 2014-03-11 |
Cyclic Crf Antagonist Peptides App 20140024802 - Rivier; Jean E. F. | 2014-01-23 |
Urocortin-iii And Uses Thereof App 20140004603 - VALE, JR.; Wylie W. ;   et al. | 2014-01-02 |
Receptor(SSTR2)-selective somatostatin antagonists Grant 8,501,687 - Rivier , et al. August 6, 2 | 2013-08-06 |
Npy Antagonists App 20120259092 - Chatenet; David ;   et al. | 2012-10-11 |
Receptor(sstr2)-selective Somatostatin Antagonists App 20110269683 - RIVIER; Jean E.F. ;   et al. | 2011-11-03 |
Receptor(SSTR2)-selective somatostatin antagonists Grant 7,960,342 - Rivier , et al. June 14, 2 | 2011-06-14 |
CRFR1 selective ligands Grant 7,851,588 - Rivier , et al. December 14, 2 | 2010-12-14 |
Urocortin proteins and uses thereof Grant 7,638,607 - Vale, Jr. , et al. December 29, 2 | 2009-12-29 |
Crfr1 Selective Ligands App 20090149629 - Rivier; Jean E.F. ;   et al. | 2009-06-11 |
CRFR1 selective ligands Grant 7,498,300 - Rivier , et al. March 3, 2 | 2009-03-03 |
Somatostatin Receptor 2 Antagonists App 20080299040 - RIVIER; Jean E. F. ;   et al. | 2008-12-04 |
Receptor(sstr2)-selective Somatostatin Antagonists App 20080260638 - Rivier; Jean E.F. ;   et al. | 2008-10-23 |
Receptor(SSTR4)-selective somatostatin analogs Grant 7,238,775 - Rivier , et al. July 3, 2 | 2007-07-03 |
Urocortin proteins and uses thereof Grant 7,223,846 - Vale, Jr. , et al. May 29, 2 | 2007-05-29 |
CRFR2 selective ligands Grant 7,141,546 - Rivier , et al. November 28, 2 | 2006-11-28 |
Conotoxins I Grant RE39,240 - Olivera , et al. August 15, 2 | 2006-08-15 |
SSTR1-selective analogs App 20060155107 - Rivier; Jean E.F. ;   et al. | 2006-07-13 |
SSTR1-selective analogs Grant 7,019,109 - Rivier , et al. March 28, 2 | 2006-03-28 |
Receptor(SSTR4)-selective somatostatin analogs App 20050245438 - Rivier, Jean E. F. ;   et al. | 2005-11-03 |
CRFR1 selective ligands App 20040204564 - Rivier, Jean E.F. ;   et al. | 2004-10-14 |
Peptides intermediates for making GnRH antagonists Grant 6,747,125 - Hoeger , et al. June 8, 2 | 2004-06-08 |
Receptor-selective somatostatin analogs Grant 6,579,967 - Rivier , et al. June 17, 2 | 2003-06-17 |
Urocortin peptides App 20030032587 - Vale, Wylie W. JR. ;   et al. | 2003-02-13 |
SSTR1-selective analogs App 20020173618 - Rivier, Jean E.F. ;   et al. | 2002-11-21 |
Cyclic CRF antagonist peptides Grant 6,323,312 - Rivier November 27, 2 | 2001-11-27 |
Cyclic CRF agonists Grant 5,824,771 - Rivier October 20, 1 | 1998-10-20 |
GNRH antagonist betides Grant 5,807,983 - Jiang , et al. September 15, 1 | 1998-09-15 |
Receptor-selective somatostatin analogs Grant 5,750,499 - Hoeger , et al. May 12, 1 | 1998-05-12 |
GnRH analogs Grant 5,744,450 - Hoeger , et al. April 28, 1 | 1998-04-28 |
Amino acids and processes for making peptides using same Grant 5,710,249 - Hoeger , et al. January 20, 1 | 1998-01-20 |
Conotoxins I Grant 5,700,778 - Olivera , et al. December 23, 1 | 1997-12-23 |
GnRH analogs Grant 5,580,957 - Hoeger , et al. December 3, 1 | 1996-12-03 |
Centrally truncated NPY cyclic peptides Grant 5,569,742 - Kirby , et al. October 29, 1 | 1996-10-29 |
Peptides of melanin concentrating hormone precursor Grant 5,530,095 - Vaughn , et al. June 25, 1 | 1996-06-25 |
GNRH antagonists XIII Grant 5,506,207 - Rivier , et al. April 9, 1 | 1996-04-09 |
Cyclic CRF analogs Grant 5,493,006 - de Miranda , et al. February 20, 1 | 1996-02-20 |
Conotoxins I Grant 5,432,155 - Olivera , et al. July 11, 1 | 1995-07-11 |
Bicyclic GnRH antagonists and a method for regulating the secretion of gonadotropins Grant 5,371,070 - Koerber , et al. December 6, 1 | 1994-12-06 |
Amino acids useful in making GnRH analogs Grant 5,352,796 - Hoeger , et al. October 4, 1 | 1994-10-04 |
GnRH analogs Grant 5,296,468 - Hoeger , et al. March 22, 1 | 1994-03-22 |
CRF antagonists Grant 5,245,009 - Kornreich , et al. * September 14, 1 | 1993-09-14 |
CRF analogs Grant 5,235,036 - Kornreich , et al. August 10, 1 | 1993-08-10 |
Method of making peptides Grant 5,169,935 - Hoeger , et al. December 8, 1 | 1992-12-08 |
GnRH analogs Grant 5,169,932 - Hoeger , et al. December 8, 1 | 1992-12-08 |
CRF analog conjugates Grant 5,132,111 - Vale, Jr. , et al. July 21, 1 | 1992-07-21 |
Cyclic GnRH antagonists Grant 5,064,939 - Rivier , et al. November 12, 1 | 1991-11-12 |
Melanin-concentrating hormones Grant 5,049,655 - Vaughan , et al. September 17, 1 | 1991-09-17 |
Cyclic GRF analogs Grant 5,043,322 - Rivier , et al. August 27, 1 | 1991-08-27 |
Potentiation of erythropoiesis Grant 5,032,507 - Yu , et al. July 16, 1 | 1991-07-16 |
NPY peptide analogs Grant 5,026,685 - Boublik , et al. June 25, 1 | 1991-06-25 |
FSH-releasing peptides Grant 4,973,577 - Vale, Jr. , et al. November 27, 1 | 1990-11-27 |
Antibodies to inhibin and conjugates produced therefrom Grant 4,864,019 - Vale , et al. September 5, 1 | 1989-09-05 |
GRF analogs VI Grant 4,784,987 - Rivier , et al. November 15, 1 | 1988-11-15 |
GnRH antagonists VIII Grant 4,740,500 - Vale, Jr. , et al. April 26, 1 | 1988-04-26 |
Human inhibin Grant 4,737,578 - Evans , et al. April 12, 1 | 1988-04-12 |
GRF analogs IIIb Grant 4,728,726 - Rivier , et al. * March 1, 1 | 1988-03-01 |
Synthesis of N-substituted peptide amides Grant 4,701,499 - Kornreich , et al. October 20, 1 | 1987-10-20 |
GnRH antagonists V Grant 4,689,396 - Roeske , et al. * August 25, 1 | 1987-08-25 |
GnRH antagonists IX Grant 4,661,472 - Rivier , et al. April 28, 1 | 1987-04-28 |
GnRH antagonists VII Grant 4,652,550 - Rivier , et al. March 24, 1 | 1987-03-24 |
Hypothalamic GRF agonists Grant 4,628,043 - Spiess , et al. December 9, 1 | 1986-12-09 |
GRF analogs II Grant 4,626,523 - Vale, Jr. , et al. December 2, 1 | 1986-12-02 |
CRF antagonists Grant 4,605,642 - Rivier , et al. August 12, 1 | 1986-08-12 |
Rat hypothalamic GRF Grant 4,595,676 - Spiess , et al. June 17, 1 | 1986-06-17 |
GnRH Antagonists IV Grant 4,569,927 - Rivier , et al. February 11, 1 | 1986-02-11 |
Synthesis of N-substituted peptide amides Grant 4,569,967 - Kornreich , et al. February 11, 1 | 1986-02-11 |
GnRH Antagonists VI Grant 4,565,804 - Rivier , et al. January 21, 1 | 1986-01-21 |
Human pancreatic GRF Grant 4,563,352 - Rivier , et al. * January 7, 1 | 1986-01-07 |
Synthetic calcitonin-gene-related peptides for lowering blood pressure or gastric acid secretion in mammals Grant 4,530,838 - Evans , et al. July 23, 1 | 1985-07-23 |
GRF Analogs Grant 4,529,595 - Rivier , et al. July 16, 1 | 1985-07-16 |
GRF Analogs IV Grant 4,528,190 - Vale, Jr. , et al. July 9, 1 | 1985-07-09 |
GRF Analogs III Grant 4,518,586 - Rivier , et al. May 21, 1 | 1985-05-21 |
CCK Agonists II Grant 4,490,364 - Rivier , et al. December 25, 1 | 1984-12-25 |
Treatment of male mammals Grant 4,489,061 - Rivier , et al. * December 18, 1 | 1984-12-18 |
rCRF and analogs Grant 4,489,163 - Rivier , et al. December 18, 1 | 1984-12-18 |
Conotoxins Grant 4,447,356 - Olivera , et al. May 8, 1 | 1984-05-08 |
GnRH Antagonists II Grant 4,444,759 - Rivier , et al. April 24, 1 | 1984-04-24 |
Analogs of somatostatin Grant 4,428,942 - Rivier , et al. January 31, 1 | 1984-01-31 |
CRF And analogs Grant 4,415,558 - Vale, Jr. , et al. November 15, 1 | 1983-11-15 |
GnRH antagonists Grant 4,409,208 - Rivier , et al. * October 11, 1 | 1983-10-11 |
Analogs of extended N-terminal somatostatin Grant 4,393,050 - Vale, Jr. , et al. July 12, 1 | 1983-07-12 |
Peptides affecting gonadal function Grant 4,382,922 - Rivier , et al. May 10, 1 | 1983-05-10 |
Mobile phase for liquid chromatography Grant 4,377,482 - Rivier March 22, 1 | 1983-03-22 |
Contraceptive treatment of male mammals Grant 4,377,574 - Rivier , et al. March 22, 1 | 1983-03-22 |
Pharmaceutically active peptides Grant 4,372,884 - Brown , et al. February 8, 1 | 1983-02-08 |
Bombesin analogs Grant 4,331,661 - Marki , et al. May 25, 1 | 1982-05-25 |
LRF Antagonists Grant 4,307,083 - Rivier , et al. December 22, 1 | 1981-12-22 |
Peptides which effect release of hormones Grant RE30,548 - Vale, Jr. , et al. March 17, 1 | 1981-03-17 |
Water-soluble peptides affecting gonadal function Grant 4,244,946 - Rivier , et al. January 13, 1 | 1981-01-13 |
Method for cyclization of peptides Grant 4,216,141 - Rivier , et al. August 5, 1 | 1980-08-05 |
Peptides which inhibit gonadal function Grant 4,215,038 - Rivier , et al. July 29, 1 | 1980-07-29 |
Peptides with para-substituted phenylalanine Grant 4,211,693 - Rivier , et al. July 8, 1 | 1980-07-08 |
Peptides having analgesic and thermoregulative properties Grant 4,207,311 - Brown , et al. June 10, 1 | 1980-06-10 |
Somatostatin analogs with dissociated biological activities Grant 4,133,782 - Vale, Jr. , et al. January 9, 1 | 1979-01-09 |
Peptides which effect release of hormones Grant 4,105,603 - Vale, Jr. , et al. August 8, 1 | 1978-08-08 |
Somatostatin and acylated des-(ala.sup.1, gly.sup.2) derivatives thereof Grant 3,904,594 - Guillemin , et al. September 9, 1 | 1975-09-09 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.